These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24659367)
41. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Su Y; Ni Z; Wang G; Cui J; Wei C; Wang J; Yang Q; Xu Y; Li F Int Immunopharmacol; 2012 Aug; 13(4):468-75. PubMed ID: 22683180 [TBL] [Abstract][Full Text] [Related]
42. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma. Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805 [TBL] [Abstract][Full Text] [Related]
43. MiR-146a functions as a small silent player in gastric cancer. Shomali N; Mansoori B; Mohammadi A; Shirafkan N; Ghasabi M; Baradaran B Biomed Pharmacother; 2017 Dec; 96():238-245. PubMed ID: 28987948 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. Peng Y; Liu YM; Li LC; Wang LL; Wu XL PLoS One; 2014; 9(4):e94422. PubMed ID: 24736504 [TBL] [Abstract][Full Text] [Related]
45. DNMT3A-mediated down-regulation of microRNA-105 promotes gastric cancer cell proliferation. Zhou GQ; Han F; Shi ZL; Yu L; Li XF; Yu C; Shen CL; Wan DW; Zhu XG; Li R; He SB Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3377-3383. PubMed ID: 28829505 [TBL] [Abstract][Full Text] [Related]
46. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. Takahashi M; Cuatrecasas M; Balaguer F; Hur K; Toiyama Y; Castells A; Boland CR; Goel A PLoS One; 2012; 7(10):e46684. PubMed ID: 23056401 [TBL] [Abstract][Full Text] [Related]
47. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
48. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964 [TBL] [Abstract][Full Text] [Related]
49. DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer. Yin H; Song P; Su R; Yang G; Dong L; Luo M; Wang B; Gong B; Liu C; Song W; Wang F; Ma Y; Zhang J; Wang W; Yu J Sci Rep; 2016 Jan; 6():18824. PubMed ID: 26729612 [TBL] [Abstract][Full Text] [Related]
50. miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1. Guo MM; Hu LH; Wang YQ; Chen P; Huang JG; Lu N; He JH; Liao CG Med Oncol; 2013 Jun; 30(2):542. PubMed ID: 23529765 [TBL] [Abstract][Full Text] [Related]
51. A microRNA DNA methylation signature for human cancer metastasis. Lujambio A; Calin GA; Villanueva A; Ropero S; Sánchez-Céspedes M; Blanco D; Montuenga LM; Rossi S; Nicoloso MS; Faller WJ; Gallagher WM; Eccles SA; Croce CM; Esteller M Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13556-61. PubMed ID: 18768788 [TBL] [Abstract][Full Text] [Related]
52. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387 [TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261 [TBL] [Abstract][Full Text] [Related]
54. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer. Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068 [TBL] [Abstract][Full Text] [Related]
55. Depletion of tumor suppressor miRNA-148a in plasma relates to tumor progression and poor outcomes in gastric cancer. Komatsu S; Imamura T; Kiuchi J; Takashima Y; Kamiya H; Ohashi T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Otsuji E Am J Cancer Res; 2021; 11(12):6133-6146. PubMed ID: 35018247 [TBL] [Abstract][Full Text] [Related]
56. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression. He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314 [TBL] [Abstract][Full Text] [Related]
57. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Hanoun N; Delpu Y; Suriawinata AA; Bournet B; Bureau C; Selves J; Tsongalis GJ; Dufresne M; Buscail L; Cordelier P; Torrisani J Clin Chem; 2010 Jul; 56(7):1107-18. PubMed ID: 20431052 [TBL] [Abstract][Full Text] [Related]
58. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10. Zheng J; Ge P; Liu X; Wei J; Wu G; Li X Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling. Song J; Guan Z; Li M; Sha S; Song C; Gao Z; Zhao Y Oncol Res; 2018 Jul; 26(6):847-856. PubMed ID: 28800791 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA-216b regulates cell proliferation, invasion and cycle progression via interaction with cyclin T2 in gastric cancer. Chen X; Zhang L; Song Q; Chen Z Anticancer Drugs; 2020 Jul; 31(6):623-631. PubMed ID: 32058347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]